AVAH vs. PNTG, TLMD, VMD, HLTH, APR, BTSG, ADUS, AHCO, EHAB, and CHE
Should you be buying Aveanna Healthcare stock or one of its competitors? The main competitors of Aveanna Healthcare include The Pennant Group (PNTG), SOC Telemed (TLMD), Viemed Healthcare (VMD), Cue Health (HLTH), Apria (APR), BrightSpring Health Services (BTSG), Addus HomeCare (ADUS), AdaptHealth (AHCO), Enhabit (EHAB), and Chemed (CHE). These companies are all part of the "medical" sector.
The Pennant Group (NASDAQ:PNTG) and Aveanna Healthcare (NASDAQ:AVAH) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, community ranking, media sentiment, profitability, risk, institutional ownership and analyst recommendations.
The Pennant Group has a net margin of 2.86% compared to The Pennant Group's net margin of -5.92%. Aveanna Healthcare's return on equity of 13.42% beat The Pennant Group's return on equity.
The Pennant Group received 10 more outperform votes than Aveanna Healthcare when rated by MarketBeat users. Likewise, 44.74% of users gave The Pennant Group an outperform vote while only 38.71% of users gave Aveanna Healthcare an outperform vote.
The Pennant Group has higher earnings, but lower revenue than Aveanna Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, The Pennant Group had 4 more articles in the media than Aveanna Healthcare. MarketBeat recorded 5 mentions for The Pennant Group and 1 mentions for Aveanna Healthcare. The Pennant Group's average media sentiment score of 1.89 beat Aveanna Healthcare's score of 0.57 indicating that Aveanna Healthcare is being referred to more favorably in the news media.
The Pennant Group currently has a consensus target price of $24.00, indicating a potential upside of 1.95%. Aveanna Healthcare has a consensus target price of $1.80, indicating a potential downside of 31.03%. Given Aveanna Healthcare's stronger consensus rating and higher probable upside, equities research analysts plainly believe The Pennant Group is more favorable than Aveanna Healthcare.
85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are held by institutional investors. 5.8% of The Pennant Group shares are held by insiders. Comparatively, 7.8% of Aveanna Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
The Pennant Group has a beta of 2.01, indicating that its stock price is 101% more volatile than the S&P 500. Comparatively, Aveanna Healthcare has a beta of 2.02, indicating that its stock price is 102% more volatile than the S&P 500.
Summary
The Pennant Group beats Aveanna Healthcare on 13 of the 18 factors compared between the two stocks.
Get Aveanna Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for AVAH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AVAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aveanna Healthcare Competitors List
Related Companies and Tools
